Striverdi Respimat Spray, Metered
Product Images NDC 0597-0192

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Striverdi Respimat (NDC 0597-0192). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boehringer Ingelheim Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Striverdi Respimat 01

FDA Label Image

Striverdi Respimat 02

This text contains data related to a clinical trial involving four different doses of Olodaterol (2ug, 5ug, 10ug, and 20ug) administered daily to a total of 326 participants. The data recorded includes the average FEV (forced expiratory volume) before and after the treatment, with the number of participants (n) cited for each dose.*

FDA Label Image

Striverdi Respimat 03

This appears to be a graph showing the comparison of FEV (Forced Expiratory Volume) between two groups, one receiving a medication called "olodaterol" and the other receiving a placebo, over a period of 8 hours. The values on the Y-axis range from 110 to 160, and the time period on the X-axis runs from 0 to 8 hours after medication dosing. However, the output may not be accurate enough to make a definitive interpretation.*

FDA Label Image

Striverdi Respimat 04

FDA Label Image

Striverdi Respimat 05

FDA Label Image

Striverdi Respimat 06

FDA Label Image

Striverdi Respimat 07

The text is describing two separate items. The first item is a "safety catch", which is not further described or defined. The second item is a "clear base", again with no further description or definition. No context is given for these items, so it is not possible to determine their purpose or significance.*

FDA Label Image

Striverdi Respimat 08

FDA Label Image

Striverdi Respimat 09

FDA Label Image

Striverdi Respimat 10

FDA Label Image

Striverdi Respimat 11

FDA Label Image

Striverdi Respimat 12

FDA Label Image

Striverdi Respimat 13

FDA Label Image

Striverdi Respimat 14

FDA Label Image

Striverdi Respimat 15

FDA Label Image

Striverdi Respimat 16

FDA Label Image

Striverdi Respimat 17

FDA Label Image

Striverdi Respimat 18

FDA Label Image

Striverdi Respimat 19

Striverdic Respimate is an olodaterol inhalation spray with an NDC of 0597-0192-61. It is designed for oral inhalation only and comes in a package that contains 4 grams of the product with 60 metered inhalations. The product should only be used as per the instructions provided by the manufacturers. A video demonstration on the correct usage of the STRIVERDI RESPIMAT inhaler is available on the manufacturer's website or by scanning the provided code. The product is made in Germany and is distributed by Boehringer Ingelheim Pharmaceuticals, Inc. The cartridge needs to be inserted before use, and the product needs to be discarded three months after insertion. Apart from these instructions, no other useful information is available due to the presence of unclear text resulting from .*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.